Works by Hye Jin Kang


Results: 119
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Won Seog Kim;
    • Hyeon Seok Eom;
    • Deok-Hwan Yang;
    • Sung Hwa Bae;
    • Hyo Jung Kim;
    • Jae Hoon Lee;
    • Suk-Joong Oh;
    • Sung-Soo Yoon;
    • Jae-Yong Kwak;
    • Chul Won Choi;
    • Min Kyoung Kim;
    • Sung Young Oh;
    • Hye Jin Kang;
    • Seung Hyun Nam;
    • Hyeok Shim;
    • Joon Seong Park;
    • Yeung-Chul Mun;
    • Cheolwon Suh
    Publication type:
    Article
    10

    Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 2, p. 684, doi. 10.4143/crt.2022.1434
    By:
    • Hyungwoo Cho;
    • Dok Hyun Yoon;
    • Dong-Yeop Shin;
    • Youngil Koh;
    • Sung-Soo Yoon;
    • Seok Jin Kim;
    • Young Rok Do;
    • Gyeong-Won Lee;
    • Jae-Yong Kwak;
    • Yong Park;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Kwai Han Yoo;
    • Won Sik Lee;
    • Byeong Bae Park;
    • Jae Cheol Jo;
    • Hyeon-Seok Eom;
    • Hyo Jung Kim;
    • Seong Hyun Jeong
    Publication type:
    Article
    11
    12

    Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 1, p. 304, doi. 10.4143/crt.2022.004
    By:
    • Kyoung Ha Kim;
    • Jae Hoon Lee;
    • Mark Lee;
    • Hoon-Gu Kim;
    • Young Rok Do;
    • Yong Park;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Seog Kim;
    • Seong Kyu Park;
    • Jee Hyun Kong;
    • Moo-Rim Park;
    • Deok-Hwan Yang;
    • Jae-Yong Kwak;
    • Hye Jin Kang;
    • Yeung-Chul Mun;
    • Jong-Ho Won
    Publication type:
    Article
    13

    Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study.

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1268, doi. 10.4143/crt.2021.1168
    By:
    • Seong Hyun Jeong;
    • Seok Jin Kim;
    • Dok Hyun Yoon;
    • Yong Park;
    • Hye Jin Kang;
    • Youngil Koh;
    • Gyeong-Won Lee;
    • Won-Sik Lee;
    • Deok-Hwan Yang;
    • Young Rok Do;
    • Min Kyoung Kim;
    • Kwai Han Yoo;
    • Yoon Seok Choi;
    • Hwan Jung Yun;
    • Jun Ho Yi;
    • Jae-Cheol Jo;
    • Hyeon-Seok Eom;
    • Jae-Yong Kwak;
    • Ho-Jin Shin;
    • Byeong Bae Park
    Publication type:
    Article
    14
    15

    Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01.

    Published in:
    Cancer Research & Treatment, 2018, v. 50, n. 2, p. 590, doi. 10.4143/crt.2017.172
    By:
    • Jung Hye Choi;
    • Tae Min Kim;
    • Hyo Jung Kim;
    • Sung Ae Koh;
    • Yeung-Chul Mun;
    • Hye Jin Kang;
    • Yun Hwa Jung;
    • Hyeok Shim;
    • So Young Chong;
    • Der-Sheng Sun;
    • Soonil Lee;
    • Byeong Bae Park;
    • Jung Hye Kwon;
    • Seung-Hyun Nam;
    • Jun Ho Yi;
    • Young Jin Yuh;
    • Jong-Youl Jin;
    • Jae Joon Han;
    • Seok-Hyun Kim
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation.

    Published in:
    Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1230629
    By:
    • Seok Jin Kim;
    • Jae-Cheol Jo;
    • Dok Hyun Yoon;
    • Deok-Hwan Yang;
    • Sang Eun Yoon;
    • Gyeong-Won Lee;
    • Jee Hyun Kong;
    • Yong Park;
    • Ka-Won Kang;
    • Ho-Sup Lee;
    • Sung Yong Oh;
    • Ho-Jin Shin;
    • Won Sik Lee;
    • Yoon Seok Choi;
    • Seong Hyun Jeong;
    • Min Kyoung Kim;
    • Hye Jin Kang;
    • Jun Ho Yi;
    • Sung-Nam Lim;
    • Ho-Young Yhim
    Publication type:
    Article
    31
    32

    Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 11, p. 2714, doi. 10.1080/10428194.2020.1783448
    By:
    • Song, Ga-Young;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Jin Seok;
    • Min, Chang-Ki;
    • Kim, Kihyun;
    • Choi, Yunsuk;
    • Eom, Hyeon-Seok;
    • Joo, Young Don;
    • Kim, Sung-Hyun;
    • Kwak, Jae-Yong;
    • Kang, Hye Jin;
    • Lee, Jae Hoon;
    • Lee, Ho Sup;
    • Mun, Yeung-Chul;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Seong Kyu;
    • Park, Yong;
    • Shin, Ho-Jin
    Publication type:
    Article
    33

    Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lymphoma

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 4, p. 1020, doi. 10.3109/10428194.2014.946027
    By:
    • Lee, Gyeong-Won;
    • Go, Se-Il;
    • Kim, Seok-Hyun;
    • Hong, Junshik;
    • Kim, Yu Ri;
    • Oh, Sukjoong;
    • Kim, Sung-Yong;
    • Do, Young Rok;
    • Lee, Hyewon;
    • Lee, Soon Il;
    • Bae, Sung Hwa;
    • Oh, Sung Yong;
    • Song, Moo Kon;
    • Lee, Won-Sik;
    • Lee, Bohee;
    • Kim, Jin Seok;
    • Kim, Min Kyoung;
    • Kang, Hye Jin;
    • Ahn, Jae-Sook;
    • Yhim, Ho-Young
    Publication type:
    Article
    34
    35
    36

    Primary Thyroid Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Clinical Manifestation and Outcome of a Rare Disease - Consortium for Improving Survival of Lymphoma Study.

    Published in:
    Acta Haematologica, 2012, v. 127, n. 2, p. 100, doi. 10.1159/000333113
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Jin Seok;
    • Kim, Seok Jin;
    • Lee, Suee;
    • Lee, Dae Ho;
    • Kang, Hye Jin;
    • Song, Moo Kon;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Kwak, Jae-Yong;
    • Park, Byeong-Bae;
    • Do, Young-Rok;
    • Jeong, Seong Hyun;
    • Suh, Cheolwon
    Publication type:
    Article
    37

    Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry.

    Published in:
    Acta Haematologica, 2009, v. 122, n. 4, p. 200, doi. 10.1159/000253027
    By:
    • Kim, Seok Jin;
    • Kim, Kihyun;
    • Kim, Byung Soo;
    • Jo, Deog-Yeon;
    • Kang, Hye Jin;
    • Kim, Jin Seok;
    • Mun, Yeung-Chul;
    • Kim, Chul Soo;
    • Sohn, Sang Kyun;
    • Eom, Hyeon-Seok;
    • Kwak, Jae-Yong;
    • Shim, Hyeok;
    • Yoon, Hwi-Joong;
    • Jin, Jong-Youl;
    • Min, Chang-Ki;
    • Shin, Hyunchoon;
    • Won, Jong-Ho;
    • Lee, Je-Jung;
    • Kwon, Jung Hye;
    • Joo, Young-Don
    Publication type:
    Article
    38

    Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study).

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 4, p. 413, doi. 10.1002/ajh.25726
    By:
    • Ho Sup Lee;
    • Kihyun Kim;
    • Seok Jin Kim;
    • Je-Jung Lee;
    • Inho Kim;
    • Jin Seok Kim;
    • Hyeon-Seok Eom;
    • Dok Hyun Yoon;
    • Cheolwon Suh;
    • Ho-Jin Shin;
    • Yeung-Chul Mun;
    • Min Kyoung Kim;
    • Sung-Nam Lim;
    • Chul Won Choi;
    • Hye Jin Kang;
    • Sung-Soo Yoon;
    • Chang-Ki Min
    Publication type:
    Article
    39

    Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1280, doi. 10.1002/ajh.24891
    By:
    • Cho, Hyungwoo;
    • Yoon, Dok Hyun;
    • Lee, Jung Bok;
    • Kim, Sung-Yong;
    • Moon, Joon Ho;
    • Do, Young Rok;
    • Lee, Jae Hoon;
    • Park, Yong;
    • Lee, Ho Sup;
    • Eom, Hyeon Seok;
    • Shin, Ho-Jin;
    • Min, Chang-Ki;
    • Kim, Jin Seok;
    • Jo, Jae-Cheol;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Lee, Won Sik;
    • Lee, Je-Jung;
    • Suh, Cheolwon;
    • Kim, Kihyun
    Publication type:
    Article
    40

    Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases.

    Published in:
    American Journal of Hematology, 2009, v. 84, n. 12, p. 826, doi. 10.1002/ajh.21557
    By:
    • Oh, Sung Yong;
    • Kim, Won Seog;
    • Kim, Seok Jin;
    • Kim, Jin Seok;
    • Kim, Sung-Hyun;
    • Lee, Dae Ho;
    • Won, Jong-Ho;
    • Hwang, In Gyu;
    • Kim, Min Kyoung;
    • Lee, Soon Il;
    • Kim, Jong Gwang;
    • Yang, Deok-Hwan;
    • Kang, Hye Jin;
    • Choi, Chul Won;
    • Park, Jinny;
    • Choi, Young Jin;
    • Kim, Hyo Jung;
    • Kwon, Jung Hye;
    • Suh, Cheolwon;
    • Kim, Hyo-Jin
    Publication type:
    Article
    41
    42
    43

    Bortezomib-Melphalan-Prednisone (VMP) Versus MP as Initial Treatment for Very Elderly Patients With Newly Diagnosed Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e70, doi. 10.1016/j.clml.2017.03.126
    By:
    • Kim, Min Kyoung;
    • Kim, Kihyun;
    • Yoon, Do Hyun;
    • Suh, Cheolwon;
    • Moon, Joon Ho;
    • Lee, Yoo Jin;
    • Lee, Jae Hoon;
    • Jung, Sung-Hoon;
    • Lee, Je-Jung;
    • Kim, Hyo Jung;
    • Bae, Sung Hwa;
    • Kim, Jin Seok;
    • Lee, Jeong-Ok;
    • Eom, Hyeon Seok;
    • Lee, Won-Sik;
    • Kang, Hye Jin;
    • Mun, Yeung-Chul;
    • Do, Young Rok;
    • Hyun, Myung Soo
    Publication type:
    Article
    44

    Phase 2 Study Using Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma; Final Analysis (KMM150).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e73, doi. 10.1016/j.clml.2017.03.133
    By:
    • Lee, Je-Jung;
    • Jung, Sung-Hoon;
    • Kim, Kihyun;
    • Kim, Jin Seok;
    • Eom, Hyeon Seok;
    • Min, Chang Ki;
    • Moon, Joon Ho;
    • Sohn, Sang Kyun;
    • Park, Yong;
    • Lee, Ho Sup;
    • Kim, Sung-Hyun;
    • Shin, Ho-Jin;
    • Joo, Young Don;
    • Yoon, Sung-Soo;
    • Park, Seong Kyu;
    • Kwak, Jae-Young;
    • Kang, Hye Jin;
    • Choi, Yunsuk;
    • Mun, Yeung-Chul;
    • Lee, Jae Hoon
    Publication type:
    Article
    45
    46
    47
    48
    49
    50